Article Details
Retrieved on: 2025-09-29 17:56:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley downgraded and cut the price target on Novo Nordisk shares, citing GLP-1 concerns.
Article found on: www.investopedia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here